Genentech is committed to the pursuit of groundbreaking science to discover and develop breakthrough medicines for people with serious and life-threatening diseases. We envision a world where all individuals can experience their full potential for health and wellbeing, and a future of science and healthcare that is more diverse, equitable, and inclusive.
Genentech is committed to supporting our existing grantees during the evolving coronavirus (COVID-19) pandemic. We understand that grantees will have their own challenges in adapting to rapidly changing events, and we will work to accommodate needs for the programs funded by Genentech.
If you are an existing grantee, please contact your Genentech representative with questions or to let us know if your program or event will be cancelled or postponed. If you are unsure of who to contact, please email [email protected] and we will direct you to the appropriate person.
For more information on Genentech’s relief and recovery efforts during the COVID-19 pandemic, please visit our COVID-19 response page.
Scientific Project Support provides funding for general research, translational research, other research or development projects, and/or other initiatives of research organizations, labs, and academic institutions. As part of our company-wide commitment to ensuring a healthier future for all patients, we prioritize projects that build a more fair and just healthcare system in the following areas:
Research collaborations, clinical trials, and associated correlative research involving or undertaken in relation to Genentech or Roche products (whether investigational and/or approved for other uses) are excluded from this type of support. For information regarding these types of programs, please refer to our pipeline.
Genentech prioritizes action-oriented research projects that are designed to build the evidence base needed to promote health equity and reduce disparities in healthcare access, quality, and outcomes amongst populations facing the greatest needs. Evidence generated from Scientific Projects should support health systems and hospitals, practitioners, advocates, and decision-makers in setting priorities and allocating resources towards solutions that improve the health and wellbeing of all patients within Genentech’s disease areas of focus.
Grant requests must be submitted at least 90 days prior to the project/program start date, and preferably 60 days prior to the date on which the organization needs to be notified of a funding decision. The following uploads are required to submit your application:
Funding Request System Resources
Learn more about the funding request process.
Operating expenses must be directly and exclusively dedicated to the activity for which the requestor is applying.
Genentech/Roche will consider funding requests in the following disease states:
In order to be eligible for this type of funding, your organization must not be:
In order to be eligible for this type of funding, the funding must not be used for:
Indirect costs cannot exceed more than 25% of the charitable grant amount.
The scientific project must not have commenced prior to the approval for funding.
Researchers assigned to the research project must be qualified (e.g., not subject to medical license suspension or revocation, not debarred or disqualified by a federal or state agency).
An organization with a written policy to discriminate based on race, religion, gender, gender expression and/or identity, age, national origin, disability, marital status, sexual orientation, military status, or any other protected status is ineligible for funding.
Requests must be submitted at least 90 days prior to the project/program start date. Decisions are made on a case-by-case basis; Genentech will be in touch regarding your proposal and you will receive a decision prior to the project/program start date.
All grants must abide by the terms in the Genentech Letter of Agreement (LOA), which is issued to an authorized signer of your organization once the application is approved. You must agree to the terms of the LOA before any funding is issued. If you have any questions on the agreement terms, please contact us at (877) 313-5778.
Note: The funding application site does not support IE8 or earlier
We support investigators in academia by supplying key reagents. Request proteins, antibodies, and cDNAs.